Use of EGF to inhibit pathogenic infections of the urogenital tract

Details for Australian Patent Application No. 2002333142 (hide)

Owner UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC.

Inventors Buret, Andre, G.; Olson, Merle, E.; Hardin, James, A.; Gall, D., Grant

Agent Cullens

Pub. Number AU-A-2002333142

PCT Number PCT/CA02/01612

PCT Pub. Number WO2003/035102

Priority 60/330,650 26.10.01 US

Filing date 25 October 2002

Wipo publication date 6 May 2003

International Classifications

A61K 038/18 Medicinal preparations containing peptides - Growth factors

A61P 013/00 Drugs for disorders of the urinary system

A61P 015/00 Drugs for genital or sexual disorders

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/330,650 26.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002333142

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333143-NOVEL PURIFIED POLYPEPTIDES INVOLVED IN NUCLEIC ACID PROCESSING

2002333141-METHOD FOR WILLIAMS-BEUREN SYNDROME DIAGNOSIS